Conflicts of interest can arise in cancer care, particularly in relationships between healthcare providers and pharmaceutical companies. Ethical guidelines require transparency and disclosure of any potential conflicts to ensure that patient care decisions are based on the best interests of the patient, rather than financial incentives.